References
- 1. Ivanisević P, Bojić L, Tomić S, et al. Clinico-epidemiological analysis of choroidal melanoma in Split Area, Croatia. Acta Med Croatica. 2011;65:257-261.
- 2. Uysal IÖ, Misir M, Polat K, et al. Primary malignant melanoma of the nasal cavity. J Craniofac Surg. 2012;23:2-5.
- 3. Yamamura K, Kondo K, Moritani S. Primary malignant melanoma of the stomach: report of a case. Surg Today. 2012;42:195-199.
- 4. Díaz-Sánchez A, Lara MÁ, Ortega P, et al. Colorectal melanoma: review of two distinct forms of presentation. Gastroenterol Hepatol. 2011;34:83-88.
- 5. Ramos JA, Ramos WE, Ramos CV. Melanoma of the female urethra. Indian J Urol. 2011;27:448-450.
- 6. Doublali M, Chouaib A, Khallouk A, et al. Primary malignant melanoma of prostate. Urol Ann. 2010;2:76-77.
- 7. Inoue M, Ishioka J, Kageyama Y, Fukuda H, Higashi Y. Primary malignant melanoma of the male urethra: a case report. Hinyokika Kiyo. 2008;54:305-308.
- 8. Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600- mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;366:707-714.
- 9. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41:2040-2059.
- 10. Anger M, Friedhofer H, Fukutaki MF, Ferreira MC, Landman G. Primary cutaneous melanoma: an 18-year study. Clinics (Sao Paulo). 2010;65:257-263.
- 11. Döme B, Hendrix JC, Paku S et al. Biological perspectives. Alternative vascularization mechanism in cancer. Pathology and therapeutic implications. Am J Pathol 2007;170:1-15.
- 12. Battisti R, Nunes DH, Weber AL, Schweitzer LC, Sgrot I. Evaluation of the epidemiological profi le and the mortality rate of the patients with primary cutaneous melanoma in Florianopolis - SC, Brazil. An Bras Dermatol. 2009;84:335-342.
- 13. Lugowska I, Kowalska M, Zdzienicki M, et al. The prognostic role of clinical factors, VEGF, IL-8 and sTNF-R1 in cutaneous melanomas at locoregional stage. Pol Merkur Lekarski. 2012;32:22-27.